疑似心肌梗死患者的医疗资源利用:RACE-IT随机临床试验的二次分析
该研究为RACE-IT阶梯楔形随机临床实施试验的预设二次分析,纳入密歇根州9家急诊科2020年7月8日至2021年4月3日连续评估的32608例疑似心肌梗死患者,比较0/1小时hs-cTnI加速方案与0/3小时标准方案对医疗资源利用的影响。结果显示,加速方案组与标准组急诊离院回家率无显著差异(58.0% vs 59.8%;AOR 1.05;95%CI 0.95-1.15),但心脏负荷试验(3.3% vs 3.9%;AOR 0.62;95%CI 0.49-0.78)、心内科会诊(8.6% vs 12.2%;AOR 0.57;95%CI 0.49-0.67)和左心导管(1.0% vs 1.2%;AOR 0.65;95%CI 0.43-0.99)的比值显著降低,急诊停留时间中位数缩短20分钟(IQR 18-24分钟),血运重建率无显著变化。作者认为该方案可在不增加血运重建率的前提下优化急诊医疗资源。
要点
- 0/1小时hs-cTnI加速方案组心脏负荷试验率3.3%(623/19103)vs 标准组3.9%(526/13505),AOR 0.62(95%CI 0.49-0.78)。
- 加速方案组心内科会诊率8.6%(1640/19103)vs 标准组12.2%(1651/13505),AOR 0.57(95%CI 0.49-0.67)。
- 加速方案组左心导管率1.0%(198/19103)vs 标准组1.2%(167/13505),AOR 0.65(95%CI 0.43-0.99)。
- 加速方案组急诊停留时间中位数缩短20分钟(IQR 18-24分钟),血运重建率无显著变化。
- 两组急诊离院回家率无显著差异:加速方案组58.0%(11082/19103)vs 标准组59.8%(8070/13505),AOR 1.05(95%CI 0.95-1.15)。
适用人群与场景
- 密歇根州9家急诊科连续纳入的疑似心肌梗死评估患者,共32608例,中位年龄59岁(IQR 45-71岁),女性18705例(57.4%)。
- 纳入时间为2020年7月8日至2021年4月3日。
处置流程与药物剂量
- 加速方案:采用0小时和1小时高敏肌钙蛋白I(hs-cTnI)方案排除心肌梗死。
- 标准方案:采用传统0小时和3小时hs-cTnI标准诊疗方案排除心肌梗死。
研究设计与关键结果
- 研究类型:RACE-IT随机临床试验的预设二次分析,阶梯楔形随机临床实施试验,在密歇根州9家急诊科开展。
- 样本量:32608例连续急诊疑似心肌梗死患者,中位年龄59岁(IQR 45-71岁),女性18705例(57.4%)。
- 主要终点:急诊离院回家率加速方案组58.0%(11082/19103)vs 标准组59.8%(8070/13505),AOR 1.05(95%CI 0.95-1.15),无显著差异。
- 心脏负荷试验:加速方案组3.3%(623/19103)vs 标准组3.9%(526/13505),AOR 0.62(95%CI 0.49-0.78),显著降低。
- 心内科会诊:加速方案组8.6%(1640/19103)vs 标准组12.2%(1651/13505),AOR 0.57(95%CI 0.49-0.67),显著降低。
- 左心导管:加速方案组1.0%(198/19103)vs 标准组1.2%(167/13505),AOR 0.65(95%CI 0.43-0.99),显著降低。
- 急诊停留时间:加速方案组中位数缩短20分钟(IQR 18-24分钟)。
- 血运重建率:无显著变化。
证据类型、等级与局限
- 证据类型:随机临床试验(RACE-IT)的预设二次分析。
- 试验注册号:ClinicalTrials.gov NCT04488913。
- 统计分析方法:统计分析于2024年7月10日至2024年9月5日进行。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在急诊采用0/1小时hs-cTnI方案排除心肌梗死,可减少心脏评估和急诊停留时间,且不增加血运重建率,该方案可优化急诊医疗资源。
指南或共识出处
- RACE-IT随机临床试验(ClinicalTrials.gov NCT04488913)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Evaluation for myocardial infarction (MI) in emergency departments (EDs) is a common, resource-intensive process. High-sensitivity cardiac troponin I (hs-cTnI) assays have become a key tool in rapidly ruling out MI, with the potential to reduce health care resource utilization.
OBJECTIVE: To determine whether a 0-hour and 1-hour (hereafter referred to as 0/1-hour) hs-cTnI accelerated protocol reduces health care resource utilization compared with a traditional 0/3-hour standard care protocol for MI exclusion in the ED.
DESIGN, SETTING, AND PARTICIPANTS: This is a prespecified secondary analysis of the RACE-IT trial, a stepped-wedge randomized clinical implementation trial conducted across 9 EDs in Michigan. The trial enrolled 32 608 consecutive ED patients evaluated for suspected MI between July 8, 2020, and April 3, 2021. Statistical analysis was conducted from July 10 to September 5, 2024.
INTERVENTIONS: The 0/1-hour hs-cTnI accelerated protocol for MI exclusion was compared with the traditional 0/3-hour standard care protocol.
MAIN OUTCOMES AND MEASURES: Main outcomes were ED discharge to home, ED length of stay, rates of cardiac stress testing, cardiology consultation, left heart catheterization, and cardiac revascularization within 30 days.
RESULTS: A total of 32 608 patients (median age, 59 years [IQR, 45-71 years]; 18 705 women [57.4%]) were included in the analysis. The rate of ED discharge to home was 58.0% for the accelerated protocol group (11 082 of 19 103) and 59.8% for the standard care group (8070 of 13 505) (adjusted odds ratio [AOR], 1.05; 95% CI, 0.95-1.15). The accelerated protocol group showed significant reductions in the odds of cardiac stress testing (3.3% [623 of 19 103] vs 3.9% [526 of 13 505]; AOR, 0.62; 95% CI, 0.49-0.78), cardiology consultations (8.6% [1640 of 19 103] vs 12.2% [1651 of 13 505]; AOR, 0.57; 95% CI, 0.49-0.67), and left heart catheterization rates (1.0% [198 of 19 103] vs 1.2% [167 of 13 505]; AOR, 0.65; 95% CI, 0.43-0.99) compared with the standard protocol group. The median ED length of stay decreased by 20 minutes (IQR, 18-24 minutes) in the accelerated protocol group, with no significant change in revascularization rates.
CONCLUSIONS AND RELEVANCE: This secondary analysis of a randomized clinical trial of a 0/1-hour hs-cTnI protocol to rule out MI in the ED found that there was a reduction in cardiac evaluations and ED length of stay without increasing revascularization rates compared with the standard 0/3-hour hs-cTnI protocol. This approach could optimize health care resources in EDs.
TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04488913.
参考来源
- Miller J, Cook B, Gunaga S, et al. Health Care Resource Utilization for Patients With Suspected Myocardial Infarction: A Secondary Analysis of the RACE-IT Randomized Clinical Trial. JAMA Netw Open. 2025. PMID: 40279128. doi:10.1001/jamanetworkopen.2025.6930
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。